Born from a decade of an industrial collaboration with an expert society in the field of therapeutics antibodies, NabGen Technology is a technological platform of the Laboratoire d’Ingénierie des Systèmes Macromoléculaires (LISM) located in Marseille, France.
Created in 2011 by Christian Cambillau (RD-CNRS emeritus) and Alain Roussel (RD-CNRS), its primary purpose was to provide innovating tools to aid crystallization: nanobodies.
Robust and stable, those biomolecules represent a versatile tool for the development of diagnostic programs, therapeutics treatments or even functional and structural characterization.
NabGen Technology offers today an extended range of services, in particular for the study of membranes proteins thanks to an innovating technology based on the use of extracellular vesicles. With more than a hundred collaborative projects treated since its launch, the platform knows a major boom those last few years.